REG - Oxford Nanopore Tech - Commencement of legal action against MGI Australia

Oxford Nanopore TechnologiesAnnouncement

Wed 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250806:nRSF1961Ua&default-theme=true

RNS Number : 1961U  Oxford Nanopore Technologies plc  06 August 2025

 

Oxford Nanopore Technologies plc 

("Oxford Nanopore" or the "Company") 

Oxford Nanopore announces commencement of legal action against
MGI Australia Pty Ltd., in the Federal Court of Australia 

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new
generation of molecular sensing technology based on nanopores, today announces
that it has launched legal action against MGI Australia Pty Ltd. et al., for
infringing four of the Company's Australian patents following the announcement
of the launch of its "Cyclone SEQ WT-02" in Australia.

Oxford Nanopore's decision to commence legal proceedings against MGI has been
carefully considered and reflects the Company's responsibility to protect the
intellectual property ("IP") that underpins its sensing platform, which is now
widely used across Research and Applied sectors in Australia.

Throughout this process the primary focus will continue to be on customers,
operations and partners. Protecting IP ensures that investments in new
technology can be made available to customers and partners.

Oxford Nanopore continually innovates, to deliver high performance
technologies to its customers. This innovation has generated substantial
proprietary IP, which is a key foundation for long-term value creation. This
IP is protected by patents granted in the U.S., Europe, Australia and other
jurisdictions. 

-ENDS-

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:     ir@nanoporetech.com (mailto:ir@nanoporetech.com)

Media:              media@nanoporetech.com
(mailto:media@nanoporetech.com)

Teneo Australia (communications adviser to the Company)

Scott McFarlane:  +61 493 119 547

Australian media: ONT-AUS@teneo.com (mailto:ONT-AUS@teneo.com)

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society
through enabling the analysis of anything, by anyone, anywhere. The Group has
developed a new generation of nanopore-based sensing technology that is
currently used for real-time, high-performance, accessible, and scalable
analysis of DNA and RNA. The technology is used in more than 125 countries,
to understand the biology of humans, plants, animals, bacteria, viruses and
environments as well as to understand diseases such as cancer.  Oxford
Nanopore's technology also has the potential to provide broad, high impact,
rapid insights in a number of areas including healthcare, food and
agriculture.

For more information please visit: www.nanoporetech.com
(http://www.nanoporetech.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPFMATMTJMMFA